SCHEMBL7227775

SCHEMBL7227775

CC(=O)N1CCn2c3c(c4cc(C)cc(c42)C1)CCCC3

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 7/20 0.57
HTR2A P28223 5/20 0.57
BAZ2B Q9UIF8 3/20 0.39
MEN1 O00255 2/20 0.38
MAPK1 P28482 2/20 0.38
KMT2A Q03164 2/20 0.38
NOTUM Q6P988 3/20 0.38
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 1/20 0.36
CREBBP Q92793 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7239323 0.86 HTR2C (0.56) HTR2CHTR2ABAZ2BMEN1MAPK1
SCHEMBL7228180 0.82 HTR2C (0.53) HTR2CHTR2ABAZ2BMEN1MAPK1
SCHEMBL5394626 0.81 HTR2C (0.54) HTR2CHTR2ABAZ2BMEN1MAPK1
SCHEMBL7723000 0.80 HTR2C (0.53) HTR2CHTR2ABAZ2BMEN1MAPK1
SCHEMBL7227653 0.73 HTR2C (1.00) HTR2CHTR2AMEN1MAPK1KMT2A
SCHEMBL11489973 0.72 BAZ2B (0.43) BAZ2BMEN1KMT2ANOTUMMAPT
SCHEMBL4063381 0.70 HTR2C (1.00) HTR2CHTR2AMEN1MAPK1KMT2A
SCHEMBL3545321 0.68 HTR2C (0.43) HTR2CHTR2ABAZ2BMEN1MAPK1
SCHEMBL12195257 0.67 HTR2C (0.64) HTR2CHTR2AMEN1MAPK1KMT2A
SCHEMBL12457155 0.66 HTR2A (0.49) HTR2CHTR2AMEN1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6503900-B2 For treatment or prevention of disorders such as obsessive-compulsive disorder, depression, anxiety, schizophrenia WYETH 2003-01-07 US disclosed
US-20020086860-A1 [1,4]Diazepino [6,7,1-jk] carbazoles and derivatives AMERICAN HOME PRODUCTS CORPORATION 2002-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020086860-A1 [1,4]Diazepino [6,7,1-jk] carbazoles and derivatives GRIK1, GRIK3, GRIK4 HTR2C 31/4885HTR2A 169/4885BAZ2B 401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.